Understanding the Effects of Prostate Cancer on Gay and Bisexual Men

了解前列腺癌对男同性恋和双性恋男性的影响

基本信息

  • 批准号:
    8927565
  • 负责人:
  • 金额:
    $ 16.53万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-09-16 至 2017-12-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This application is in response to PA-12-113, Research on the Health of LGBTI Populations, which "encourages researchers to investigate new questions related to LGBTI health" with "high priority placed on research on interventions for [LGBTI] individuals." Survivorship of prostate cancer (PCa) is one such area. Across the lifespan, 1-in-6 gay and bisexual men (GBM) and 1-in-3 male couples will be diagnosed with PCa, making PCa the most common cancer affecting GBM. Yet, almost no research has examined the effects of PCa treatment on GBM's sexual functioning. Sexual dysfunction is the major sequela of PCa treatment, which is deeply distressing in itself, and negatively impacts quality of life post-treatment, resulting in serious negative mental health outcomes. Recent studies indicate sexual outcomes of PCa treatment are significantly worse for GBM than heterosexual men. Physiological differences between anal sex and vaginal sex likely explain, at least in part, this health disparity. Tailored treatment needs to be developed, but is almost entirely unexplored. Missing is research to evaluate the effects of PCa treatment on GBM sexual functioning, research on rehabilitation outcomes, and research to guide development of new treatments tailored to GBM and sex between men. The long-term objective of this research is to develop the first evidence-based PCa rehabilitation curriculum tailored for GBM. As a first step, in this R21 we will conduct the formative research needed to estimate the extent of poor outcomes, confirm need, and assess acceptability and feasibility. There are three specific aims. In Aim 1, we will investigate, in-depth, the experience of PCa treatment on the sexual lives of GBM, their partners, and their relationships. We will conduct a semi-structured, chat or phone interview study of up to 48 GBM PCa patients, partners, and couples, nationally. In Aim 2, we will refine definitions and develop the measures needed to assess sexual dysfunction in GBM. In Aim 3, we will conduct an online quantitative survey of 220 GBM with PCa, which will a) quantify sexual challenges post-treatment, b) assess needs and priorities for rehabilitation, c) develop a new scale to measure sexual functioning in GBM and d) assess the acceptability and feasibility of a new rehabilitation curriculum for GBM with PCa.
描述(由申请人提供):本申请是对PA-12-113,LGBTI人群健康研究的回应,该研究“鼓励研究人员调查与LGBTI健康相关的新问题”,“高度重视[LGBTI]个人干预研究”。“前列腺癌(PCa)的生存就是这样一个领域。在整个生命周期中,六分之一的同性恋和双性恋男性(GBM)和三分之一的男性伴侣将被诊断患有PCa,使PCa成为影响GBM的最常见癌症。然而,几乎没有研究检查PCa治疗对GBM性功能的影响。性功能障碍是PCa治疗的主要后遗症,其本身令人深感痛苦,并对治疗后的生活质量产生负面影响,导致严重的负面心理健康结果。最近的研究表明,PCa治疗的性结局对GBM来说比异性恋男性明显更差。肛交和阴道性交之间的生理差异可能至少部分解释了这种健康差异。定制治疗需要开发,但几乎完全没有探索。缺少的是评估PCa治疗对GBM性功能影响的研究,康复结果的研究,以及指导开发针对GBM和男性性别的新治疗方法的研究。 本研究的长期目标是开发第一个针对GBM的循证PCa康复课程。作为第一步,在R21中,我们将进行必要的形成性研究,以估计不良结局的程度,确认需求,并评估可接受性和可行性。有三个具体目标。在目标1中,我们将深入研究PCa治疗对GBM性生活、其伴侣及其关系的影响。我们将在全国范围内对多达48名GBM PCa患者、伴侣和夫妇进行半结构化、聊天或电话访谈研究。在目标2中,我们将完善定义并制定评估GBM性功能障碍所需的措施。在目标3中,我们将对220名患有前列腺癌的GBM进行在线定量调查,该调查将a)量化治疗后的性挑战,B)评估康复需求和优先事项,c)开发新的量表来衡量GBM的性功能,d)评估新的康复课程对患有前列腺癌的GBM的可接受性和可行性。

项目成果

期刊论文数量(19)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The Influence of Companion Animals on Quality of Life of Gay and Bisexual Men Diagnosed with Prostate Cancer.
伴侣动物对诊断患有前列腺癌的同性恋和双性恋男性生活质量的影响。
The Reliability of Self-Reported Gleason Scores in Studies of Sexual Minority Prostate Cancer Survivors.
  • DOI:
    10.1097/upj.0000000000000086
  • 发表时间:
    2020-05
  • 期刊:
  • 影响因子:
    0.8
  • 作者:
    Rosser BRS;Konety BR;Capistrant BD;Kapoor A;Polter E
  • 通讯作者:
    Polter E
Prostate cancer disclosure and sexual orientation: Understanding outness to healthcare providers as a situational or consistent phenomenon.
  • DOI:
    10.1016/j.pec.2021.11.017
  • 发表时间:
    2022-07
  • 期刊:
  • 影响因子:
    3.5
  • 作者:
    Wells-Prado, Daniel R.;Ross, Michael W.;Rosser, B. R. Simon;Polter, Elizabeth J.;Capistrant, Bea D.;Haggart, Ryan;Kohli, Nidhi;Konety, Badrinath R.;Mitteldorf, Darryl;Talley, Kristine M. C.;West, William;Wheldon, Christopher W.
  • 通讯作者:
    Wheldon, Christopher W.
The Effects of Prostate Cancer Treatment on Role-In-Sex in Gay and Bisexual Men: Mixed Methods Results from the Restore-1 and Restore-2 Studies.
前列腺癌治疗对男同性恋和双性恋男性性角色的影响:Restore-1 和 Restore-2 研究的混合方法结果。
  • DOI:
    10.1080/00224499.2022.2128027
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    3.6
  • 作者:
    Tatum,Alexander;Rosser,BRSimon;Wheldon,ChristopherW;Torres,MariaBeatriz;Bates,AlexJ;Haggart,Ryan;Konety,BadrinathR;Mitteldorf,Darryl;Polter,ElizabethJ;Ross,MichaelW;Talley,KristineMC;West,William;Wright,MorganM;Zhang,
  • 通讯作者:
    Zhang,
Every urologist and oncologist should know about treating sexual and gender minority prostate cancer patients: translating research findings into clinical practice.
  • DOI:
    10.21037/tau-20-1052
  • 发表时间:
    2021-07
  • 期刊:
  • 影响因子:
    2
  • 作者:
    Rosser BRS;Rider GN;Kapoor A;Talley KMC;Haggart R;Kohli N;Konety BR;Mitteldorf D;Polter EJ;Ross MW;West W;Wheldon C;Wright M
  • 通讯作者:
    Wright M
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

B R Simon Rosser其他文献

B R Simon Rosser的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('B R Simon Rosser', 18)}}的其他基金

Testing Effective Methods to Recruit Sexual and Gender Minority Cancer Patients for Cancer Studies
测试招募性少数癌症患者进行癌症研究的有效方法
  • 批准号:
    10771387
  • 财政年份:
    2022
  • 资助金额:
    $ 16.53万
  • 项目类别:
Training the Long-Term Services and Supports Dementia Care Workforce in Provision of Care to Sexual and Gender Minority Residents
培训长期服务和支持痴呆症护理人员,为性少数群体居民提供护理
  • 批准号:
    10523826
  • 财政年份:
    2022
  • 资助金额:
    $ 16.53万
  • 项目类别:
Testing Effective Methods to Recruit Sexual and Gender Minority Cancer Patients for Cancer Studies
测试招募性少数癌症患者进行癌症研究的有效方法
  • 批准号:
    10515913
  • 财政年份:
    2022
  • 资助金额:
    $ 16.53万
  • 项目类别:
Testing Effective Methods to Recruit Sexual and Gender Minority Cancer Patients for Cancer Studies
测试招募性少数癌症患者进行癌症研究的有效方法
  • 批准号:
    10683296
  • 财政年份:
    2022
  • 资助金额:
    $ 16.53万
  • 项目类别:
Training the Long-Term Services and Supports Dementia Care Workforce in Provision of Care to Sexual and Gender Minority Residents
培训长期服务和支持痴呆症护理人员,为性少数群体居民提供护理
  • 批准号:
    10703475
  • 财政年份:
    2022
  • 资助金额:
    $ 16.53万
  • 项目类别:
Restore: Improving Sexual Outcomes of Gay and Bisexual Prostate Cancer Survivors
恢复:改善同性恋和双性恋前列腺癌幸存者的性结果
  • 批准号:
    9980806
  • 财政年份:
    2017
  • 资助金额:
    $ 16.53万
  • 项目类别:
Restore: Improving Sexual Outcomes of Gay and Bisexual Prostate Cancer Survivors
恢复:改善同性恋和双性恋前列腺癌幸存者的性结果
  • 批准号:
    9528534
  • 财政年份:
    2017
  • 资助金额:
    $ 16.53万
  • 项目类别:
Restore: Improving Sexual Outcomes of Gay and Bisexual Prostate Cancer Survivors
恢复:改善同性恋和双性恋前列腺癌幸存者的性结果
  • 批准号:
    10206046
  • 财政年份:
    2017
  • 资助金额:
    $ 16.53万
  • 项目类别:
Understanding the Effects of Prostate Cancer on Gay and Bisexual Men
了解前列腺癌对男同性恋和双性恋男性的影响
  • 批准号:
    8767750
  • 财政年份:
    2014
  • 资助金额:
    $ 16.53万
  • 项目类别:
Men's INTernet Study III (MINTS-III) for HIV Prevention
预防艾滋病毒的男性互联网研究 III (MINTS-III)
  • 批准号:
    8444676
  • 财政年份:
    2010
  • 资助金额:
    $ 16.53万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 16.53万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 16.53万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 16.53万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 16.53万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 16.53万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 16.53万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 16.53万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 16.53万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 16.53万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 16.53万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了